Injective (INJ) is currently trading at $6.76, reflecting an 8.81% increase over the past 24 hours. The daily range has been relatively tight, with a high of $6.79 and a low of $6.16, indicating strong market activity within this band.

Volume stands at approximately 87.14 million, translating to a volume-to-market cap ratio of 12.89%, suggesting healthy trading liquidity. The hourly moving averages are showing bullish momentum, with the 8 SMA at $6.48 (+4.35%) and the 13 SMA at $6.45 (+4.83%), indicating short-term upward trends, while the 144 SMA at $6.83 is trending slightly negative at -0.97%.

The 1-hour Relative Strength Index (RSI) is currently at 73, which indicates that INJ is nearing overbought conditions in the short term. In contrast, the 7-day RSI sits at 47, suggesting a neutral position, while the 14-day price change of 4.27% shows some recovery potential after a significant drop of 13.78% over the last week and a more considerable 21.99% decline over the past 30 days.

Despite the recent uptick, INJ's price remains significantly below its all-time high of $52.62 reached in March 2024, indicating potential for substantial upside should market conditions stabilize. The mixed signals from the RSI readings and recent price changes suggest caution, with short-term bullishness tempered by longer-term bearish trends.

Based on this analysis, the recommendation for Injective (INJ) is to Hold. This position allows traders to capitalize on short-term gains while monitoring for broader market stability and potential reversal patterns that could signal a more favorable entry point for buying.